what are the glp 1 agonists GLP-1 Receptor – From Evolution to Revolution Can one drug do it
Description
The collaborations lead project is a once-monthly GLP-1 receptor agonist, initially targeting obesity and type 2 diabetes
12 Of particular interest, a 20-week research trial involving nondiabetic patients with a mean body mass index of 30 to 40 kg/m 2 at baseline compared the weight loss effects of liraglutide versus orlistat 120 mg three times daily or placebo
All authors read and approved the final manuscript
Abdi AM, Pasiou E, Konstantopoulos P, Driva TS, Kontos A, Papagianni E, et al
